DENTSPLY SIRONA Inc
NASDAQ:XRAY

Watchlist Manager
DENTSPLY SIRONA Inc Logo
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Watchlist
Price: 18.59 USD -0.11% Market Closed
Market Cap: 3.7B USD
Have any thoughts about
DENTSPLY SIRONA Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one XRAY stock under the Base Case scenario is 47.32 USD. Compared to the current market price of 18.59 USD, DENTSPLY SIRONA Inc is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XRAY Relative Value
Base Case
47.32 USD
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
98
vs Industry
59
Median 3Y
1.8
Median 5Y
2.1
Industry
2.3
Forward
1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.8
Industry
23
Forward
9.9
More Details
6.9
P/OCF
P/OCF
Price to OCF
6.9
vs History
98
vs Industry
29
Median 3Y
14.4
Median 5Y
15.5
Industry
14.3
More Details
7.2
P/FCFE
P/FCFE
Price to FCFE
7.2
vs History
98
vs Industry
21
Median 3Y
25.6
Median 5Y
20.2
Industry
20
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
98
vs Industry
48
Median 3Y
2
Median 5Y
2
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
98
vs Industry
53
Median 3Y
2.1
Median 5Y
2.4
Industry
2.4
Forward
1.3
More Details
2.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.6
vs History
98
vs Industry
57
Median 3Y
3.9
Median 5Y
4.4
Industry
5
More Details
8.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.5
vs History
98
vs Industry
31
Median 3Y
12.2
Median 5Y
13.3
Industry
12.9
Forward
7.7
More Details
19.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.8
vs History
85
vs Industry
18
Median 3Y
23.8
Median 5Y
25.3
Industry
17.4
Forward
11
More Details
9.7
EV/OCF
EV/OCF
Enterprise Value to OCF
9.7
vs History
98
vs Industry
25
Median 3Y
16.9
Median 5Y
18
Industry
14
More Details
14.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.2
vs History
98
vs Industry
19
Median 3Y
24.2
Median 5Y
22.6
Industry
18.2
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
98
vs Industry
56
Median 3Y
1.2
Median 5Y
1.3
Industry
1.9
More Details

Multiples Across Competitors

XRAY Competitors Multiples
DENTSPLY SIRONA Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
3.7B USD 0.9 -8.9 8.5 19.8
JP
Hoya Corp
TSE:7741
7.1T JPY 8.6 36.2 23.9 28.8
CH
Alcon AG
SIX:ALC
37.7B CHF 4.2 35.7 17.5 33.9
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.2 22.1
KR
HLB Inc
KOSDAQ:028300
10.5T KRW 201.6 -56.4 -86.8 -81.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.1B CNY 11.5 27.6 24 24
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.6B USD 4.4 15.4 10.5 12.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.4 16.7 56.1
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.4 264.6 462.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Average P/E: 33.8
Negative Multiple: -8.9 		N/A N/A
JP
Hoya Corp
TSE:7741
36.2
15%
2.4
CH
Alcon AG
SIX:ALC
35.7
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -56.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.4
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.4 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.4
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3

See Also

Summary
XRAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
XRAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XRAY stock valuation using valuation multiples.
Wall Street Estimates
XRAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XRAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.